無料プレビュー

Tempus AI, Inc. (TEM) · NASDAQ

プロフィール

Tempus AI is a healthcare technology company that develops Intelligent Diagnostics by applying artificial intelligence to laboratory test results and clinical data. The company offers diagnostic testing services through five laboratories performing NGS, PCR, and molecular pathology tests across oncology, hereditary conditions, neuropsychiatry, and cardiology. Tempus operates two product lines—Diagnostics (laboratory tests) and Data & Applications (data licensing, clinical trial matching, and algorithmic diagnostics)—leveraging a proprietary multimodal database of over 8.6 million de-identified

主要指標

株価: $69.28 (-1.52%)
時価総額: 121億ドル
PER（今期予想）: -312.8
PBR: 28.0
配当利回り: —
52週レンジ: $40.77 – $101.56
業種: Healthcare / Medical - Healthcare Information Services
上場: NASDAQ
構成銘柄: —

比較会社: NTRA Natera, Inc.、ILMN Illumina, Inc.、DGX Quest Diagnostics Incorporated、GH Guardant Health, Inc.、BTSG BrightSpring Health Services, Inc. Common Stock、QGEN Qiagen N.V.、SGFY Signify Health, Inc.、HQY HealthEquity, Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-03 · 更新: 2026-10-09